Probably the best quarterly I've seen for painchek. Although I got it wrong with the FDA timelines. Clinical trial hasn't even started yet. Forecast to begin Q4 CY22. Sales in NZ,Scotland,England,Wales and 60% of RACs in Australia. So much to look forward to! $585k receipts from customers for the qtr. The growth continues. Very positive.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 497311 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 254838 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PCK (ASX) Chart |